UNSPSC 85891827: High dose rate (hdr) brachytherapy of pituitary gland using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of pituitary gland using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DG109BZ

UNSPSC 85891827 High dose rate (hdr) brachytherapy of pituitary gland using palladium 103 (pd-103) is a Commodity code that shows no relevant recent state and local procurement activity. The single opportunity posted under this code—Santa Clara County Health System's RFSQHHSFY270052 for temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, ophthalmology, orthopedic, respiratory care, sterile processing, surgical/operating room, and therapy services—falls outside the narrow scope of specialized brachytherapy treatment for pituitary gland tumors. The temporary staffing solicitation, with proposals due October 7, 2026, is unrelated to the high-precision radiation oncology procedures the code nominally describes.

The mismatch between the code's stated scope and the single recent opportunity suggests that this Commodity code does not drive material state and local procurement volume, or that procurement offices are misclassifying health staffing services under medical treatment codes. Business development professionals should verify the correct UNSPSC family for temporary clinical staffing (likely within health care support services) and monitor whether Santa Clara County's qualification vehicle generates follow-on contract activity. No geographic spread, issuing-body pattern, or representative opportunity stream supporting the code's intended scope is evident in current state and local activity.